Our people

Research Team

A multi-disciplinary group of pathologists, scientists, clinicians, surgeons and statisticians, working together on adult ocular tumours.

Group Lead

Prof Sarah Coupland

Prof Sarah Coupland

Professor & Honorary Consultant in Pathology · Group Lead

Laboratory Team

Dr Helen Kalirai

Dr Helen Kalirai

Senior Postdoctoral Research Fellow

Dr Karen Aughton

Dr Karen Aughton

Senior Postdoctoral Research Fellow

Dr Sam Barlow

Dr Sam Barlow

Senior Molecular Analyst

Clinical Team — Ocular Oncologists

Prof Heinrich Heimann

Prof Heinrich Heimann

Consultant Ophthalmologist · Lead, Liverpool Ocular Oncology Centre

Dr Rumana Hussain

Dr Rumana Hussain

Consultant Ophthalmologist

Prof Bertil Damato

Prof Bertil Damato

Honorary Consultant Ophthalmologist · Co-founder

Clinical Team — Surgery & Statistics

Mr Stephen Fenwick

Mr Stephen Fenwick

Consultant Hepatobiliary Surgeon, UHLG

Prof Azzam Taktak

Prof Azzam Taktak

Consultant Clinical Scientist · Mathematical & Statistical Modelling

Dr Antonio Eleuteri

Dr Antonio Eleuteri

Medical Physics, Royal Liverpool University Hospital

Postgraduate Students

Mr James Draper

Mr James Draper

PhD Student · Choroidal embryology & biology

Mr Josh Hattersley

Mr Josh Hattersley

PhD Student · Extracellular matrix in uveal melanoma

Mr Max Jackson

Mr Max Jackson

PhD Student · AI application to eye cancer diagnostics

Miss Natalie Woods

Miss Natalie Woods

PhD Student · Uveal melanoma immune evasion

Associate Members

Prof Judy Coulson

Prof Judy Coulson

Professor in Cellular & Molecular Physiology

Dr Joseph Sacco

Dr Joseph Sacco

Consultant in Medical Oncology, Clatterbridge Cancer Centre

Dr Carlos R. Figueiredo

Dr Carlos R. Figueiredo

Postdoctoral Research Associate

Dr Andrew Fielding

Dr Andrew Fielding

North West Cancer Research Lecturer, Lancaster University

Postdoctoral & collaboration enquiries

We welcome enquiries from prospective postdoctoral researchers, PhD students and collaborators who share our commitment to improving outcomes in ocular oncology.

Email the group